In short, Moringa powder supplements are transforming immunity by providing a natural, nutritional armor for the body.

Atsena Therapeutics (“Atsena” or “the Company”), a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced ...

The randomized, double-blind, placebo-controlled trial aims to assess the safety, tolerability, and efficacy of intranasal foralumab in patients with na-SPMS, a form of multiple sclerosis (MS) ...

Previously cultivated in Ontario, the iconic Jean Guy strain has now found its new home in "la belle province," allowing Tilray to harness the capabilities of its high-performance facility in Québec.

We are encouraged by the FDA’s Fast Track designation for BIIB080, which highlights the urgent need for innovative treatments targeting tau pathology in Alzheimer’s disease,” said Priya Singhal, M.D., ...

Aurora Spine remains dedicated to advancing spinal health through continuous innovation and collaboration with leading medical professionals. The publication of this study reinforces the company's ...

EMERYVILLE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA”; NASDAQ: XOMA), the biotech royalty aggregator, announced today Chief Investment Officer, Brad Sitko, will be a ...

Cartesian Therapeutics is a clinical-stage company pioneering cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a CAR-T entering Phase 3 clinical ...

The Grove AI Advisory Board brings together distinguished experts in global pharmaceutical strategy, AI innovation, and regulatory compliance. Advisory members will collaborate directly with Grove ...

A live webcast of the Needham Virtual Healthcare Conference presentation can be accessed through the Events & Presentations section of the company’s website at investors.ovidrx.com. An archived replay ...

A live webcast and replay of the fireside chat will be available on the Events & Presentations page in the Investor Relations section of Pyxis Oncology’s website, ir.pyxisoncology.com. About Pyxis ...

About Sensei Biotherapeutics Sensei Biotherapeutics (Nasdaq: SNSE) is a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer ...